About Us
Overview
Our Business
Board of Directors
Executive Leadership Team
Biocon Biologics Malaysia
Scientific Publications
Awards & Recognition
Our Legacy
Products
Overview
Product Locator
Business
Overview
Global Biosimilars Portfolio
Oncology
Immunology
Diabetology
Ophthalmology
Bone Health & Others
Global Footprint
Partners
Branded Formulations India
Metabolics
Oncology
Immunotherapy
Nephrology
CCD
COVID-19 Care Portfolio
Capabilities
Research & Development
Quality & Compliance
Global Scale Manufacturing
Biocon Biologics Malaysia
Commitment
Overview
Investors
Overview
Governance & Policies
News
Overview
Press Releases
Company Statements
Stories
Media Contacts
Careers
Working With Us
Now Hiring
Stories
Contact Us
Brand Stories
Employee Stories
Patient Stories
Press Releases 2016
Biocon Biologics
/
News – Posts
/
Press Releases
/
Press Releases 2016
Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data
Tue, 27-Dec-2016
Posted by: Biocon Biologics
No Comments
Biocon Features in Asia IP Elite 2016 List
Fri, 09-Dec-2016
Posted by: Biocon Biologics
No Comments
Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI
Tue, 29-Nov-2016
Posted by: Biocon Biologics
No Comments
Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India
Fri, 11-Nov-2016
Posted by: Biocon Biologics
No Comments
Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab
Tue, 08-Nov-2016
Posted by: Biocon Biologics
No Comments
Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency
Thu, 03-Nov-2016
Posted by: Biocon Biologics
No Comments
Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year
Fri, 28-Oct-2016
Posted by: Biocon Biologics
No Comments
Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.
Thu, 20-Oct-2016
Posted by: Biocon Biologics
No Comments
Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business
Mon, 19-Sep-2016
Posted by: Biocon Biologics
No Comments
Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France
Thu, 01-Sep-2016
Posted by: Biocon Biologics
No Comments
1
2